Furthermore, there are several suggestions in the literature that the FXR1 may have a role in cancer associated with cMYC, PNPT1, p21, p27, TERC, and p53. The number of potential FXR1-binding oncogenes/tumor suppressor mRNAs might increase this list even more. This evidence concerns the gene MYC and cancer.